Skip to main content

Curley Joanne's Form 4 filing

Vera Therapeutics, Inc. (VERA) · filed Sep 22, 2022

Accession no.
0001209191-22-051002
Filed
Sep 22, 2022
Trade date
Sep 20-21, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 16 non-derivative transactions and 4 derivative transactions. Open-market sales total $348.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Curley JoanneCIK 0001857670Officer (Chief Development Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 20, 2022Class A Common StockMOption exerciseAcquired+978$6.37+$6,229.8629,775Direct
Sep 20, 2022Class A Common StockSSaleDisposed−978$20.54F2−$20,088.1228,797Direct
Sep 20, 2022Class A Common StockMOption exerciseAcquired+100$6.37+$63728,897Direct
Sep 20, 2022Class A Common StockSSaleDisposed−100$21.00−$2,10028,797Direct
Sep 20, 2022Class A Common StockMOption exerciseAcquired+1,828$2.90+$5,301.230,625Direct
Sep 20, 2022Class A Common StockSSaleDisposed−1,828$20.48F3−$37,437.4428,797Direct
Sep 20, 2022Class A Common StockMOption exerciseAcquired+334$2.90+$968.629,131Direct
Sep 20, 2022Class A Common StockSSaleDisposed−334$20.92F4−$6,987.2828,797Direct
Sep 20, 2022Class A Common StockMOption exerciseAcquired+2,314$11.00+$25,45431,111Direct
Sep 20, 2022Class A Common StockSSaleDisposed−2,314$20.24F5−$46,835.3628,797Direct
Sep 20, 2022Class A Common StockMOption exerciseAcquired+10,112$11.00+$111,23238,909Direct
Sep 20, 2022Class A Common StockSSaleDisposed−10,112$20.80F6−$210,329.628,797Direct
Sep 21, 2022Class A Common StockMOption exerciseAcquired+910$11.00+$10,01029,707Direct
Sep 21, 2022Class A Common StockSSaleDisposed−910$21.13F7−$19,228.328,797Direct
Sep 21, 2022Class A Common StockMOption exerciseAcquired+264$11.00+$2,90429,061Direct
Sep 21, 2022Class A Common StockSSaleDisposed−264$22.35F8−$5,900.428,797Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 20, 2022Class A Common StockMOption exerciseDisposed−1,078$0.00$011,873Direct
Sep 20, 2022Class A Common StockMOption exerciseDisposed−2,162$0.00$042,436Direct
Sep 20, 2022Class A Common StockMOption exerciseDisposed−12,426$0.00$090,491Direct
Sep 21, 2022Class A Common StockMOption exerciseDisposed−1,174$0.00$089,317Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.96 to $20.90, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $20.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.87 to $21.00, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.68 to $20.58, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $21.06, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.74 to $21.58, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.09 to $22.62, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)